Cello Group (CLL)
CLL Share PerformanceMore
|52 week high||118.50 09/02/17|
|52 week low||83.75 18/02/16|
|52 week change||31.25 (37.09%)|
|4 week volume||3,487,130 24/01/17|
Latest News« previous» nextMore
17/02/2017 - 13:38 Interactive Investor
Growth companies by their very nature often have parts of the business that could become huge in the future. Former AI...
17/02/2017 - 10:40 RNS
RNS Number: 1911X Cello Group plc 17 February 2017 Cello Group plc Result of General Meeting Cello Group plc (AIM: CLL; "Cello", the "Group" or the "Company"), the healthcare focused strategic marketing group, is pleased to announce that at its General Meeting held earlier today, all resolutions in connection with the conditional placing of 10,309,279 new ordinar...
01/02/2017 - 08:03 StockMarketWire
Cello Group has raised 15.0m, gross, through a placing of 15,463,919 new ordinary shares at 0.97 and will use part of the proc...
01/02/2017 - 07:00 RNS
RNS Number: 6663V Cello Group plc 01 February 2017 For Immediate Release 1 February 2017 Cello Group plc Placing to raise 15.0m and acquisition of Defined Health Cello Group plc (AIM: CLL; "Cello", the "Group" or the "Company), the healthcare focused strategic marketing group, is pleased to announce that it has raised 15.0 million (before expenses) by way of a...
19/01/2017 - 08:05 StockMarketWire
Cello Group said it delivered an encouraging trading performance in the year to the end of December with gross profit an...
19/01/2017 - 07:00 RNS
RNS Number: 5386U Cello Group plc 19 January 2017 For Immediate Release 19 January 2017 Cello Group plc Pre close trading statement Cello Group plc (AIM: CLL; "Cello" or "the Group"), the healthcare focused strategic marketing group, today announces a trading update for the year ended 31 December 2016. The Group has delivered an encouraging trading perfo...
31/10/2016 - 15:58 RNS
RNS Number: 9032N Cello Group plc 31 October 2016 Cello Group plc Total Voting Rights In conformity with the FCA's Disclosure and Transparency Rules, Cello Group plc ("Cello" or the "Company") confirms the following: As at 31 October 2016 Cello's issued share capital consists of 87,596,492 ordinary shares of 10 pence each ("Ordinary Shares"). The Company hol...
28/10/2016 - 10:37 RNS
RNS Number: 7609N Cello Group plc 28 October 2016 28 October 2016 Cello Group plc ("Cello" or the "Company") Director/PDMR Shareholding The Company has received notification that on 27 October 2016, Jane Shirley, a director of Cello Health, exercised share options over 90,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at an avera...
|Dividend yield||2.476 %|
Latest discussion posts More
“I was wondering why they raised the extra money. So brokers reckon its for further acquisitions. I hope so, but I was feeling a tad cautious and trimmed my holding a bit ...”▼
“Finn cap 132p tgt from shares mag Cello has US biotech opportunity in its sights Big demand for shares as marketing firm builds war chest for acquisition Tom ...”▼
“Hmm, more non-cash impairment charges and non-headine restructuring charge. Like to see an end to those. On the plus side, PULSAR into profit and do we see some retrieval ...”▼
Codes & Symbols
|Symbols||CLL, LSE:CLL, CLL.L, CLL:LN, LON:CLL, XLON:CLL|